Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
© 2019, Springer-Verlag Italia S.r.l., part of Springer Nature. Aims: To provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under...
Saved in:
Main Authors: | Catharina Busch, Samantha Fraser-Bell, Matias Iglicki, Marco Lupidi, Aude Couturier, Voraporn Chaikitmongkol, Ermete Giancipoli, Patricio J. Rodríguez-Valdés, Pierre Henry Gabrielle, Inês Laíns, Ana Rita Santos, Zafer Cebeci, Atchara Amphornphruet, Valentin Degenhardt, Jan Darius Unterlauft, Carlo Cagini, Valérie Mané-Tauty, Giuseppe D’Amico Ricci, Isaac Hindi, Kushal Agrawal, Jay Chhablani, Anat Loewenstein, Dinah Zur, Matus Rehak |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074074965&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/67601 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
by: Catharina Busch, et al.
Published: (2018) -
OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant
by: Dinah Zur, et al.
Published: (2018) -
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study
by: Matias Iglicki, et al.
Published: (2019) -
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study
by: Catharina Busch, et al.
Published: (2019) -
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity
by: Catharina Busch, et al.
Published: (2020)